ACOXL
protein-codingacyl-CoA oxidase like
Gene summary
Predicted to enable acyl-CoA oxidase activity; fatty acid binding activity; and flavin adenine dinucleotide binding activity. Predicted to be involved in fatty acid beta-oxidation using acyl-CoA oxidase. Located in cytosol. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~386.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACOXL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001142807.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 91 | 6 | 97 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 97 | 6 | 0 | 103 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001136279.1 | 17 | MANE Select | |
| Ensembl | ENSP00000407761.1 | 17 | MANE Select | |
| RefSeq | NP_001352416.1 | 10 | Standard | |
| RefSeq | NP_001358183.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of lipids
- Beta-oxidation of pristanoyl-CoA
- Peroxisomal lipid metabolism
- Metabolism
- Fatty acid metabolism
Biological Process
- biological_process
- fatty acid beta-oxidation using acyl-CoA oxidase
- lipid homeostasis
Molecular Function
- molecular_function
- acyl-CoA oxidase activity
- fatty acid binding
- pristanoyl-CoA oxidase activity
- flavin adenine dinucleotide binding
Cellular Component
- cellular_component
- peroxisome
- peroxisomal matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000439055
- Coding exons
- 17
- Length
- 385650
- Individuals with no LoFs
- 124140
- Homozygous LoFs
- 132
- Heterozygous LoFs
- 1476
- Defined
- 125748
- p
- 0.00641
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.02 | 286 | 339 | 0.844 | 0.0000184 | 3772 |
| Missense (PolyPhen) | 70 | 93.333 | 0.75 | 1139 | ||
| Synonymous | 0.934 | 122 | 136 | 0.898 | 0.00000772 | 1139 |
| Loss of Function | 1.11 | 26 | 32.9 | 0.790 | 0.00000157 | 382 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.078 | 0.066 | notable |
| Latino/Admixed American | 0.0052 | 0.0051 | notable |
| Ashkenazi Jewish | 0.010 | 0.010 | notable |
| East Asian | 0.00077 | 0.00076 | rare |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.0020 | 0.0019 | notable |
| South Asian | 0.00069 | 0.00065 | rare |
| Other | 0.0052 | 0.0052 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0796
Intolerance Scores
- LoFtool
- 0.338
- RVIS EVS
- 1.87
- RVIS percentile EVS
- 97.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.117
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |